Lakefront Biotherapeutics (LKFT) Dividends Paid - Common (2016 - 2026)
Lakefront Biotherapeutics (LKFT) posted quarterly Dividends Paid - Common of $78.2 million for Q1 2026, down 31.2% year-over-year from $113.7 million in Q1 2025, and up 1027.77% quarter-over-quarter from -$8.4 million in Q3 2025.
Lakefront Biotherapeutics (LKFT) Dividends Paid - Common (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has reported Dividends Paid - Common for 10 consecutive years, with $78.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Dividends Paid - Common fell 31.2% year-over-year to $78.2 million; the TTM figure through Mar 2026 stood at $142.3 million (down 18.15% YoY), while the FY2021 annual figure was $2.6 billion, changed N/A from the prior year.
- Dividends Paid - Common climbed to $78.2 million in Q1 2026 per LKFT's latest filing, from -$8.4 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $1.4 billion in Q1 2022 and bottomed at -$41.2 million in Q2 2025.
- Historically, Dividends Paid - Common has averaged $193.7 million across 5 years, with a median of $78.2 million in 2026.
- On a YoY basis, Dividends Paid - Common climbed as much as 54.32% in 2025 and fell as far as 3564.69% in 2025.
- Lakefront Biotherapeutics' Dividends Paid - Common stood at $1.4 billion in 2022, then slumped by 90.54% to $133.2 million in 2023, then tumbled by 113.85% to -$18.5 million in 2024, then surged by 54.32% to -$8.4 million in 2025, then jumped by 1027.77% to $78.2 million in 2026.
- Business Quant data shows LKFT's Dividends Paid - Common at $78.2 million in Q1 2026, -$8.4 million in Q3 2025, and -$41.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 34.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Lakefront Biotherapeutics | 1.81 Bn | -1.68 Bn | 1.97 Mn | 78.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.21 Mn |
| Mar 31, 2026 | 78.21 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Sep 30, 2025 | -8.43 Mn |
| Jun 30, 2025 | -41.20 Mn |
| Jun 30, 2025 | -41.20 Mn |
| Mar 31, 2025 | 113.67 Mn |
| Mar 31, 2025 | 113.67 Mn |
| Sep 30, 2024 | -18.46 Mn |
| Sep 30, 2024 | -18.46 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Jun 30, 2024 | -1.12 Mn |
| Mar 31, 2024 | 79.71 Mn |
| Mar 31, 2024 | 79.71 Mn |
| Mar 31, 2023 | 133.24 Mn |
| Mar 31, 2023 | 133.24 Mn |
| Mar 31, 2022 | 1.41 Bn |
| Mar 31, 2022 | 1.41 Bn |
| Jun 30, 2021 | 106.81 Mn |
| Jun 30, 2021 | 106.81 Mn |